andrewmstern.bsky.social
Neurologist and Alzheimer disease scientist at Brigham and Women’s Hospital. My lab studies beta-amyloid aggregates as they occur in human brain. Also TDP-43 biomarkers. Associate PD for research at MGB neurology residency program. sternlab.bwh.harvard.edu
👤 Joined on 30 December 2023
Followers
Following
Total Posts
@andrewmstern.bsky.socialNot Found
Not Found
Not Found
Not Found
Not Found
Not Found
Not Found
diane369.bsky.social
Not Found
hacimllih.bsky.social
Not Found
Not Found
Not Found
Not Found
Not Found
Not Found
Not Found
Not Found
Not Found
Not Found
jeffreycarterx.bsky.social
irinaschneider.bsky.social
Not Found
Not Found
Not Found
I agree. Oligomers have been a distraction for too long.
Show PostThank you Alzforum for highlighting our preprint! It's incredibly helpful to get the experts' feedback this early on in the publishing stage! www.alzforum.org/news/researc...
Show PostOur newest paper studying immunosuppressive astrocyte-GBM interactions using RABID-seq is out in @nature.com today! Congrats to Brian Andersen and Camilo Faust Akl! www.nature.com/articles/s41...
Show PostYes, it's multifactorial but I did find it interesting that your work suggests it's not per se the differences in CAA preference as you suggest. And to @drtfromkc.bsky.social - modified dosing does decrease ARIA. Donanemab increased ARIA in E3 but modified dose/escalation reduces it.
Show Post